Bacteriophage as an Antibacterial Agent: A Patent Perspective

References

• Harada LK , SilvaEC, CamposWFet al. Biotechnological applications of bacteriophages: state of the art. Microbiol. Res.212, 38–58 (2018).
   PubMedGoogle Scholar
• Rios AC , MoutinhoCG, PintoFCet al. Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiol. Res.191, 51–80 (2016).
   PubMed Web of Science ®Google Scholar
• Chan BK , AbedonST. Phage therapy pharmacology: phage cocktails. Adv. Appl. Microbiol.78, 1–23 (2012).
   PubMed Web of Science ®Google Scholar
• Moye ZD , WoolstonJ, SulakvelidzeA. Bacteriophage applications for food production and processing. Viruses10(4), 205 (2018).
   PubMed Web of Science ®Google Scholar
• Pereira C , CostaP, DuarteJet al. Phage therapy as a potential approach in the biocontrol of pathogenic bacteria associated with shellfish consumption. Int. J. Food Microbiol.338, 1089–1095 (2020).
   Web of Science ®Google Scholar
• Pereira C , CostaP, PinheiroLet al. Kiwifruit bacterial canker: an integrative view focused on biocontrol strategies. Planta253(2), 1–20 (2021).
   Web of Science ®Google Scholar
• Pinheiro LA , PereiraC, BarrealMEet al. Use of phage ϕ6 to inactivate Pseudomonas syringaepv. actinidiae in kiwifruit plants: in vitro and ex vivo experiments. Appl. Microbiol. Biotechnol.104(3), 1319–1330 (2020).
   PubMed Web of Science ®Google Scholar
• Pinheiro LA , PereiraC, FrazãoCet al. Efficiency of phage ϕ6 for biocontrol of Pseudomonas syringaepv. syringae: an in vitro preliminary study. Microorganisms.7(9), 286 (2019).
   PubMed Web of Science ®Google Scholar
• OPTIPHARM . Bacteriophage. www.optipharm.co.kr/ENG/ourbusiness/bacteriophage01.php
   Google Scholar
• Singh VP . Recent approaches in food biopreservation-a review. Open Vet. J.8(1), 104–111 (2018).
   PubMedGoogle Scholar
• García P , RodríguezL, RodríguezA, MartínezB. Food biopreservation: promising strategies using bacteriocins, bacteriophages and endolysins. Trends Food Sci. Technol.21(8), 373–382 (2010).
   Web of Science ®Google Scholar
• Goodridge LD . Bacteriophage biocontrol of plant pathogens: fact or fiction?Trends Biotechnol.22(8), 384–385 (2004).
   PubMed Web of Science ®Google Scholar
• Jones JB , JacksonLE, BaloghBet al. Bacteriophages for plant disease control. Annu. Rev. Phytopathol.45, 245–262 (2007).
   PubMed Web of Science ®Google Scholar
• Balogh B , JonesJB, IriarteFB, MomolMT. Phage therapy for plant disease control. Curr. Pharm. Biotechnol.11(1), 48–57 (2010).
   PubMed Web of Science ®Google Scholar
• Lukman C , YonathanC, MagdalenaS, WaturangiDE. Isolation and characterization of pathogenic Escherichia coli bacteriophages from chicken and beef offal. BMC Res. Notes.13, 1–7 (2020).
   PubMed Web of Science ®Google Scholar
• Xia G , WolzC. Phages of Staphylococcus aureus and their impact on host evolution. Infect. Genet. Evol.21, 593–601 (2014).
   PubMed Web of Science ®Google Scholar
• Switt AI , SulakvelidzeA, WiedmannMet al. Salmonella phages and prophages: genomics, taxonomy, and applied aspects. Salmonella.237–287 (2015).
   Google Scholar
• Knezevic P , ObrehtD, CurcinSet al. Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation. J. Appl. Microbiol.111(1), 245–254 (2011).
   PubMed Web of Science ®Google Scholar
• ICTV . Virus Taxonomy: Release 2020. https://talk.ictvonline.org/taxonomy
   Google Scholar
• Thung TY , LeeE, PremarathneJMet al. Bacteriophages and their applications. Food Research.2(5), 404–414 (2018).
   Google Scholar
• Lopes A , TavaresP, PetitMAet al., Automated classification of tailed bacteriophages according to their neck organization. BMC genomics.15(1), 1–7 (2014).
   PubMedGoogle Scholar
• World Health Organization . www.who.int/
   Google Scholar
• Rodríguez-Baño J , RossoliniGM, SchultszCet al. Key considerations on the potential impacts of the COVID-19 pandemic on AMR research and surveillance. J. Glob. Antimicrob. Resist.115(10), 1122–1129 (2021).
   Google Scholar
• Pelfrene E , BotgrosR, CavaleriM. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?Antimicrob Resist Infect Control.10(1), 1–6 (2021).
   PubMed Web of Science ®Google Scholar
• Mathur A , GuptaYK. Antimicrobials overuse in COVID-19: a silent pandemic of antimicrobial resistance. Indian Pract.74(5), 28–31 (2021).
   Google Scholar
• Heydargoy MH . The effect of the prevalence of Covid-19 on arbitrary use of antibiotics. Iran. J. Microbiol.14(4), 374–378 (2020).
   Google Scholar
• Kahn LH , BergeronG, BourassaMWet al. From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture. Ann. N. Y. Acad.1441(1), 31–39 (2019).
   PubMed Web of Science ®Google Scholar
• Podolsky SH . The evolving response to antibiotic resistance (1945–2018). Palgrave Commun.4(1), 1–8 (2018).
   Google Scholar
• Chan BK , AbedonST. Phage therapy pharmacology: phage cocktails. Adv. Appl. Microbiol.78, 1–23 (2012).
   PubMed Web of Science ®Google Scholar
• Drulis-Kawa Z , Majkowska-SkrobekG, MaciejewskaBet al. Learning from bacteriophages-advantages and limitations of phage and phage-encoded protein applications. Curr. Protein Pept. Sci.13(8), 699–722 (2012).
   PubMed Web of Science ®Google Scholar
• Asokan GV , RamadhanT, AhmedE, SanadH. WHO global priority pathogens list: a bibliometric analysis of Medline-PubMed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med. J.34(3), 184 (2019).
   PubMedGoogle Scholar
• Lago K , DeckerCF, ChungKK, BlythD. Difficult to treat infections in the burn patient. Surg. Infect.22(1), 95–102 (2021).
   PubMed Web of Science ®Google Scholar
• van Langeveld I , GagnonRC, ConradPFet al. Multiple-drug resistance in burn patients: a retrospective study on the impact of antibiotic resistance on survival and length of stay. J. Burn Care Res.38(2), 99–105 (2017).
   PubMed Web of Science ®Google Scholar
• US National Library of Medicine . Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa wound infections in burned patients (PHAGOBURN) (2015). https://clinicaltrials.gov/ct2/show/NCT02116010
   Google Scholar
• US National Library of Medicine . Phage therapy for the prevention and treatment of wound infections in burned patients (2020). https://clinicaltrials.gov/ct2/show/NCT04323475
   Google Scholar
• Casas V , MaloyS. Role of bacteriophage-encoded exotoxins in the evolution of bacterial pathogens. Future Microbiol.6(12), 1461–1473 (2011).
   PubMed Web of Science ®Google Scholar
• McCallin S , SacherJC, ZhengJ, ChanBK. Current state of compassionate phage therapy. Viruses11(4), 343 (2019).
   PubMed Web of Science ®Google Scholar
• Zhvania P , HoyleNS, NadareishviliLet al. Phage therapy in a 16-year-old boy with Netherton syndrome. Front. Med.4, 94 (2017).
   PubMed Web of Science ®Google Scholar
• Patey O , McCallinS, MazureHet al. Clinical indications and compassionate use of phage therapy: personal experience and literature review with a focus on osteoarticular infections. Viruses11(1), 18 (2019).
   Web of Science ®Google Scholar
• Fischetti VA . Development of phage lysins as novel therapeutics: a historical perspective. Viruses.10(6), 310 (2018).
   PubMed Web of Science ®Google Scholar
• Vandenheuvel D , LavigneR, BrüssowH. Bacteriophage therapy: advances in formulation strategies and human clinical trials. Annu. Rev. Virol.2, 599–618 (2015).
   PubMed Web of Science ®Google Scholar
• Malik DJ , SokolovIJ, VinnerGKet al. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv. Colloid Interface Sci.249, 100–133 (2017).
   PubMed Web of Science ®Google Scholar
• Esteban PP , AlvesDR, EnrightMCet al. Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions. Biotechnol. Prog.30(4), 932–944 (2014).
   PubMed Web of Science ®Google Scholar
• Esteban PP , JenkinsAT, ArnotTC. Elucidation of the mechanisms of action of bacteriophage K/nano-emulsion formulations against S. aureus via measurement of particle size and zeta potential. Colloids Surf. B.139, 87–94 (2016).
   PubMed Web of Science ®Google Scholar
• Cortes P , Cano-SarabiaM, ColomJet al. Nano/micro formulations for bacteriophage delivery. In: Bacteriophage Therapy.Humana Press, NY, USA, 271–283 (2018).
   Google Scholar
• Reardon S . Modified viruses deliver death to antibiotic-resistant bacteria. Nature546(7660), 586–587 (2017).
   PubMed Web of Science ®Google Scholar